Total Funding: 43000000
Headquarters: Herzliya, Tel Aviv, Israel
Employee Number: 11-50
Estimated Revenue: $1M to $10M
Last Funding Type: Series C
Technology: Intracellular communication
Investor Type: Late Stage Venture
Last Funding Date: 2020
Investors Number: 7
Founded Date: 2015-01-01
Industry: Longevity Medicine